Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor γ in the MCF-7 breast cancer cell line

Abstract

BRCA1 has been linked to the genetic susceptibility of a majority of familial breast and ovarian cancers. Several lines of evidence indicate that BRCA1 is a tumor suppressor and its expression is downregulated in sporadic breast and ovarian cancer cases. Therefore, the identification of genes involved in the regulation of BRCA1 gene expression might lead to new insights into the pathogenesis and treatment of these tumors. Peroxisome proliferator-activated receptor gamma (PPARγ) is a member of the nuclear receptor superfamily that has well-established roles in the regulation of adipocyte development and glucose homeostasis. More recently, it has been shown that ligands of PPARγ have a potent antitumorigenic activity in breast cancer cells. In the present study we have found that two distinct ligands of PPARγ; 15-deoxy-Δ-12,14-prostaglandin J2 (15dPG-J2) and rosiglitazone, increase the levels of BRCA1 protein in human MCF-7 breast cancer cells. Immunofluorescence microscopy analysis showed that, after treatment with 15dPG-J2, the BRCA1 protein is mainly localized in the nucleus. Functional analysis by transient transfection of different 5′-flanking region fragments, as well as gel mobility shift assays and mutagenic analysis, suggests that the effects of 15dPG-J2 and rosiglitazone are mediated through a functional DR1 located between the nucleotides −241 and −229, which is a canonical PPARγ type response element. Our data suggest that PPARγ is a crucial gene regulating BRCA1 gene expression and might therefore be important for the BRCA1 regulatory pathway involved in the pathogenesis of sporadic breast and ovarian cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aranda A and Pascual A . (2001). Physiol. Rev., 81, 1269–1304.

  • Baer R and Ludwig T . (2002). Curr. Opin. Genet. Dev., 12, 86–91.

  • Budhram-Mahadeo V, Ndisang D, Ward T, Weber BL and Latchman DS . (1999). Oncogene, 18, 6684–6691.

    Article  CAS  Google Scholar 

  • Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P and Bosca L . (2000). Mol. Cell. Biol., 20, 1692–1698.

  • Catteau A, Harris WH, Xu CF and Solomon E . (1999). Oncogene, 18, 1957–1965.

    Article  CAS  Google Scholar 

  • Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK and Lee WH . (1995). Science, 270, 789–791.

    Article  CAS  Google Scholar 

  • Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG and Rosen EM . (2001). Oncogene, 20, 77–87.

    Article  CAS  Google Scholar 

  • Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID and Rosen EM . (1999). Science, 284, 1354–1356.

  • Forman BM, Chen J and Evans RM . (1996). Ann NY Acad. Sci., 804, 266–275.

  • Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM and Evans RM . (1995). Cell, 83, 803–812.

    Article  CAS  Google Scholar 

  • Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD and Haber DA . (1999). Cell, 97, 575–586.

    Article  CAS  Google Scholar 

  • Jiang C, Ting AT and Seed B . (1998). Nature, 391, 82–86.

    Article  CAS  Google Scholar 

  • Lebovitz HE and Banerji MA . (2001). Recent. Prog. Horm. Res., 56, 265–294.

  • MacLachlan TK, Somasundaram K, Sgagias M, Shifman Y, Muschel RJ, Cowan KH and El-Deiry WS . (2000). J. Biol. Chem, 275, 2777–2785.

  • Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W and Archer TK . (1998). Oncogene, 16, 1161–1169.

    Article  CAS  Google Scholar 

  • Menendez-Hurtado A, Santos A and Perez-Castillo A . (2000). Endocrinology, 141, 4164–4170.

    Article  Google Scholar 

  • Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S and Spiegelman BM . (1998). Mol Cell, 1, 465–470.

  • Nathanson KL, Wooster R, Weber BL and Nathanson KN . (2001). Nat. Med., 7, 552–556.

  • Picard F and Auwerx J . (2002). Annu. Rev. Nutr., 22, 167–197.

    Article  CAS  Google Scholar 

  • Pignatelli M, Cortes-Canteli M, Lai C, Santos A and Perez-Castillo A . (2001). J. Cell. Sci., 114, 4117–4126.

  • Rosen ED and Spiegelman BM . (2001). J. Biol. Chem., 276, 37731–37734.

    Article  CAS  Google Scholar 

  • Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S and Livingston DM . (1996). Science, 272, 123–126.

    Article  CAS  Google Scholar 

  • Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G and Glass CK . (2000). Proc. Natl. Acad. Sci. USA, 97, 4844–4849.

  • Suen TC and Goss PE . (1999). J. Biol. Chem., 274, 31297–31304.

    Article  CAS  Google Scholar 

  • Thakur S and Croce CM . (1999). J. Biol. Chem., 274, 8837–8843.

    Article  CAS  Google Scholar 

  • Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP and Polakis P . (1996). J. Biol. Chem., 271, 28630–28635.

    Article  CAS  Google Scholar 

  • Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT . (1995). Nat. Genet., 9, 444–450.

  • Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC and Johnson DG . (2000). J. Biol. Chem., 275, 4532–4536.

    Article  CAS  Google Scholar 

  • Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ and Slamon DJ . (1999). Nat. Genet., 21, 236–240.

  • Xu CF, Chambers JA and Solomon E . (1997). J. Biol. Chem., 272, 20994–20997.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work has been supported by grants from the Dirección General de Enseñanza Superior e Investigación Científica, Grants BMC2001-2342 (APC) and PM99-0057 (AS) and by the Comunidad de Madrid, Grant 08.5/0078/2000 (AS). MP is a fellow of the Fondo de Investigaciones Sanitarias de la Seguridad Social.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Perez-Castillo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pignatelli, M., Cocca, C., Santos, A. et al. Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor γ in the MCF-7 breast cancer cell line. Oncogene 22, 5446–5450 (2003). https://doi.org/10.1038/sj.onc.1206824

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206824

Keywords

This article is cited by

Search

Quick links